Athanor Capital, LP Forma Therapeutics Holdings, Inc. Transaction History

Athanor Capital, LP

  • $24.6 Million
  • Q4 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$22.86 - $30.95 $392,506 - $531,411
-17,170 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$24.58 - $42.82 $659,284 - $1.15 Million
-26,822 Reduced 60.97%
17,170 $481,000
Q4 2020

Feb 16, 2021
BUY
$34.9 - $51.08 $523,674 - $766,455
15,005 Added 51.76%
43,992 $1.54 Million
Q3 2020

Nov 16, 2020
BUY
$32.95 - $50.25 $955,121 - $1.46 Million
28,987 New
28,987 $1.45 Million

Others Institutions Holding FMTX

# of Institutions
2
Shares Held
26.5K
Call Options Held
0
Put Options Held
0
View Full List

About Forma Therapeutics Holdings, Inc.

FMTX Quotes by TradingView
  • Ticker FMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,860,400
  • Market Cap $958M
  • Description
  • Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...
More about FMTX
Track This Portfolio

Track Athanor Capital, LP Portfolio

Follow Athanor Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Athanor Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email